Literature DB >> 30239069

The Emergency Medicine Specimen Bank: An Innovative Approach To Biobanking In Acute Care.

Jessica L Saben1,2, Shelby K Shelton1,2, Andrew J Hopkinson1,2, Brandon J Sonn1,2,3, Eleanor B Mills1,2, Makayla Welham1,2, Megan Westmoreland1,2,3, Richard Zane1,2, Adit A Ginde1,2, Kelly Bookman1,2, Justin Oeth1, Mark Chavez1, Michael DeVivo1, Alison Lakin4, John Heldens4,5, Laurie Blumberg Romero1, Michael J Ames1,6, Emily R Roberts7, Matthew Taylor1,6,7,8, Kristy Crooks1,6,9,7, Stephen J Wicks7, Kathleen C Barnes1,6,7, Andrew A Monte1,2,7,3.   

Abstract

The Emergency Medicine Specimen Bank (EMSB) was developed to facilitate precision medicine in acute care. The EMSB is a biorepository of clinical health data and biospecimens collected from all adult English- or Spanish-speaking individuals who are able and willing to provide consent and are treated at the UCHealth-University of Colorado Hospital Emergency Department. The EMSB is the first acute care biobank that seeks to enroll all patients, with all conditions who present to the ED. Acute care biobanking presents many challenges that are unique to acute care settings such as providing informed consent in a uniquely stressful and fast-paced environment and collecting, processing, and storing samples for tens of thousands of patients per year. Here, we describe the process by which the EMSB overcame these challenges and was integrated into clinical workflow allowing for operation 24 hours a day, 7 days a week at a reasonable cost. Other institutions can implement this template, further increasing the power of biobanking research to inform treatment strategies and interventions for common and uncommon phenotypes in acute care settings.
© 2018 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2018        PMID: 30239069      PMCID: PMC6428625          DOI: 10.1111/acem.13620

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  14 in total

Review 1.  Biobanking Comes of Age: The Transition to Biospecimen Science.

Authors:  Jim Vaught
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

2.  The precision medicine initiative: a new national effort.

Authors:  Euan A Ashley
Journal:  JAMA       Date:  2015-06-02       Impact factor: 56.272

Review 3.  How does race/ethnicity influence pharmacological response to asthma therapies?

Authors:  Mario Cazzola; Luigino Calzetta; Maria Gabriella Matera; Nicola A Hanania; Paola Rogliani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-03-12       Impact factor: 4.481

4.  Federal Policy for the Protection of Human Subjects. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2017-01-19

5.  Characterization of rapid extraction protocols for high-throughput metabolomics.

Authors:  Sarah Gehrke; Julie A Reisz; Travis Nemkov; Kirk C Hansen; Angelo D'Alessandro
Journal:  Rapid Commun Mass Spectrom       Date:  2017-09-15       Impact factor: 2.419

Review 6.  Impact of race and gender on antithrombotic therapy.

Authors:  Davide Capodanno; Dominick J Angiolillo
Journal:  Thromb Haemost       Date:  2010-07-20       Impact factor: 5.249

Review 7.  The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.

Authors:  Anosheh Afghahi; Allison W Kurian
Journal:  Curr Treat Options Oncol       Date:  2017-05

Review 8.  Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine?

Authors:  Alexander T Limkakeng; Andrew A Monte; Christopher Kabrhel; Michael Puskarich; Laura Heitsch; Ephraim L Tsalik; Nathan I Shapiro
Journal:  Acad Emerg Med       Date:  2016-10-03       Impact factor: 3.451

Review 9.  The coming era of precision medicine for intensive care.

Authors:  Jean-Louis Vincent
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

Review 10.  Genes, cells, and biobanks: Yes, there's still a consent problem.

Authors:  Timothy Caulfield; Blake Murdoch
Journal:  PLoS Biol       Date:  2017-07-25       Impact factor: 8.029

View more
  4 in total

1.  Modeling Clinical Processes to Consent Research Donors of Remnant Biospecimens in an Outpatient Cardiology Clinic.

Authors:  Stephanie E Soares; Nicholas R Anderson; Leslie J Solis; Javier E López
Journal:  Biopreserv Biobank       Date:  2019-12-26       Impact factor: 2.300

2.  Host methylation predicts SARS-CoV-2 infection and clinical outcome.

Authors:  Iain R Konigsberg; Bret Barnes; Monica Campbell; Elizabeth Davidson; Yingfei Zhen; Olivia Pallisard; Meher Preethi Boorgula; Corey Cox; Debmalya Nandy; Souvik Seal; Kristy Crooks; Evan Sticca; Genelle F Harrison; Andrew Hopkinson; Alexis Vest; Cosby G Arnold; Michael G Kahn; David P Kao; Brett R Peterson; Stephen J Wicks; Debashis Ghosh; Steve Horvath; Wanding Zhou; Rasika A Mathias; Paul J Norman; Rishi Porecha; Ivana V Yang; Christopher R Gignoux; Andrew A Monte; Alem Taye; Kathleen C Barnes
Journal:  Commun Med (Lond)       Date:  2021-10-26

3.  Methods and implementation of a pediatric asthma pharmacogenomic study in the emergency department setting.

Authors:  Jennifer N Fishe; Rebecca K Higley; Deirdre Casey; Lamont Hogans; Todd W Wylie; Phyllis L Hendry; Morgan Henson; Andrew Bertrand; Kathryn V Blake
Journal:  Pharmacogenet Genomics       Date:  2020-12       Impact factor: 2.000

4.  The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.

Authors:  Iman Osman; Paolo Cotzia; Una Moran; Douglas Donnelly; Carolina Arguelles-Grande; Sandra Mendoza; Andre Moreira
Journal:  J Transl Med       Date:  2020-06-01       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.